2 results for "ras-inhibitor"
A new drug cuts death risk by 60% in advanced pancreatic cancer, with 13.2 months median survival vs 6.7 for chemo.
New oral drug extends survival by 2.4 months in advanced pancreatic cancer, offering hope where options were scarce.
